Drug Company Under Fire After Revealing Dengue Vaccine May Harm Some

The Philippines government has begun investigations into the rollout of the dengue immunization program by Sanofi, which has come under fire for discounting early warnings that its vaccine could put some people at heightened risk of a severe form of the disease. The situation has become a public-relations debacle for the drugmaker, and the backlash has alarmed researchers who worry that Sanofi’s stumble could stoke mistrust in vaccines around the globe